• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
The 2011 Leading Pharmaceutical Companies R&D Expenditures and Major Programs Product Image

The 2011 Leading Pharmaceutical Companies R&D Expenditures and Major Programs

  • Published: October 2010
  • Region: World
  • 160 Pages
  • Venture Planning Group (VPG)

FEATURED COMPANIES

  • AstraZeneca
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Novartis
  • MORE

For each company, the report provides:<ul><li>Annual R&D budget.</li><li>Research facilities and staff.</li><li>New technologies, drugs, and indications in development, including their phase and anticipated introduction dates.</li></ul>The companies analyzed in the report:        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   WyethContains 160 pages

- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos